CCM
AGN

Consonance Capital Management’s Allergan plc AGN Stock Holding History

Consonance Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-95,000
Closed -$25.5M – 24
2016
Q1 		$25.5M Buy
+95,000
New +$27.2M 3.85% 14

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Consonance Capital Management's AGN Position: Q2 2016 in Review

Consonance Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 95,000 shares — an estimated $25.5M sold.

Consonance Capital Management first reported a position in AGN in Q1 2016 and held it in 1 quarter. The position peaked at $25.5M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Consonance Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Consonance Capital Management sold 95,000 Allergan plc shares in Q2 2016, an estimated $25.5M.
  • Consonance Capital Management first reported a position in Allergan plc in Q1 2016 and held it in 1 quarter.
  • Consonance Capital Management's Allergan plc position peaked at $25.5M in Q1 2016.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Consonance Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.